Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Monte Rosa Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +48 vs. Q1 2021
- Shares held
- 32.1M
- +32.1M vs. Q1 2021
- Total value
- $705.1M
- +$705.1M vs. Q1 2021
- New holders
- 48
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 192 | $2.24B |
| Q1 2026 | 191 | $1.43B |
| Q4 2025 | 161 | $1.01B |
| Q3 2025 | 129 | $444.9M |
| Q2 2025 | 116 | $280.6M |
| Q1 2025 | 106 | $276.2M |
| Q4 2024 | 105 | $423.3M |
| Q3 2024 | 81 | $263.7M |
| Q2 2024 | 75 | $171.7M |
| Q1 2024 | 68 | $281.3M |
| Q4 2023 | 71 | $226.6M |
| Q3 2023 | 71 | $201.4M |
| Q2 2023 | 68 | $272.3M |
| Q1 2023 | 69 | $309.8M |
| Q4 2022 | 66 | $313.8M |
| Q3 2022 | 70 | $328.8M |
| Q2 2022 | 57 | $375.0M |
| Q1 2022 | 52 | $559.9M |
| Q4 2021 | 53 | $742.0M |
| Q3 2021 | 56 | $759.4M |
| Q2 2021 | 48 | $705.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 7,703,205 | $174.9M | 2.28% | +7,703,205 | New |
| FMR LLC | 4,312,259 | $93.5M | 0.01% | +4,312,259 | New |
| Cormorant Asset Management, LP | 3,193,973 | $69.5M | 2.71% | +3,193,973 | New |
| Avoro Capital Advisors LLC | 3,311,434 | $62.2M | 1.08% | +3,311,434 | New |
| Price T Rowe Associates Inc | 2,737,654 | $61.3M | 0.01% | +2,737,654 | New |
| BlackRock Inc. | 1,549,885 | $35.2M | 0.00% | +1,549,885 | New |
| Aisling Capital Management LP | 1,472,331 | $33.4M | 5.35% | +1,472,331 | New |
| Alphabet Inc. | 1,464,015 | $33.2M | 0.68% | +1,464,015 | New |
| RTW Investments, LP | 1,214,572 | $25.2M | 0.38% | +1,214,572 | New |
| Casdin Capital, LLC | 960,883 | $21.8M | 0.55% | +960,883 | New |
| Deerfield Management Company, L.P. (Series C) | 350,000 | $7.95M | 0.14% | +350,000 | New |
| OrbiMed Advisors LLC | 350,000 | $7.95M | 0.08% | +350,000 | New |
| Jennison Associates LLC | 300,000 | $6.81M | 0.00% | +300,000 | New |
| Avidity Partners Management LP | 300,000 | $6.81M | 0.18% | +300,000 | New |
| Logos Global Management LP | 300,000 | $6.81M | 0.58% | +300,000 | New |
| Octagon Capital Advisors LP | 238,045 | $5.40M | 1.12% | +238,045 | New |
| Millennium Management LLC | 235,102 | $5.34M | 0.01% | +235,102 | New |
| Woodline Partners LP | 208,068 | $4.72M | 0.09% | +208,068 | New |
| Suvretta Capital Management, LLC | 150,000 | $3.40M | 0.05% | +150,000 | New |
| Alliancebernstein L.P. | 139,095 | $3.16M | 0.00% | +139,095 | New |
| Sectoral Asset Management Inc | 129,633 | $2.94M | 0.24% | +129,633 | New |
| Ratan Capital Management LP | 120,000 | $2.72M | 0.24% | +120,000 | New |
| Monashee Investment Management LLC | 120,000 | $2.72M | 0.33% | +120,000 | New |
| Goldman Sachs Group Inc | 108,500 | $2.46M | 0.00% | +108,500 | New |
| Voya Investment Management LLC | 104,177 | $2.36M | 0.00% | +104,177 | New |
| Vanguard Group Inc | 100,000 | $2.27M | 0.00% | +100,000 | New |
| HealthCor Management, L.P. | 100,000 | $2.27M | 0.09% | +100,000 | New |
| Sphera Funds Management Ltd. | 100,000 | $2.27M | 0.22% | +100,000 | New |
| Pura Vida Investments, LLC | 100,000 | $2.27M | 0.16% | +100,000 | New |
| Citadel Advisors LLC | 95,792 | $2.17M | 0.00% | +95,792 | New |
| Soleus Capital Management, L.P. | 75,000 | $1.70M | 0.26% | +75,000 | New |
| LMR Partners LLP | 58,500 | $1.33M | 0.02% | +58,500 | New |
| Hound Partners, LLC | 49,995 | $1.14M | 0.06% | +49,995 | New |
| Alyeska Investment Group, L.P. | 50,000 | $1.14M | 0.01% | +50,000 | New |
| Caas Capital Management LP | 50,000 | $1.14M | 0.06% | +50,000 | New |
| Pinz Capital Management, LP | 43,700 | $992.0K | 0.30% | +43,700 | New |
| TD Asset Management Inc | 38,764 | $950.0K | 0.00% | +38,764 | New |
| Norges Bank | 30,000 | $681.0K | 0.00% | +30,000 | New |
| Squarepoint Ops LLC | 28,209 | $640.0K | 0.00% | +28,209 | New |
| Point72 Asset Management, L.P. | 25,000 | $568.0K | 0.00% | +25,000 | New |
| Ghisallo Capital Management LLC | 20,000 | $454.0K | 0.02% | +20,000 | New |
| Qube Research & Technologies Ltd | 13,100 | $297.0K | 0.00% | +13,100 | New |
| Point72 Hong Kong Ltd | 10,606 | $241.0K | 0.02% | +10,606 | New |
| Tudor Investment Corp Et Al | 10,000 | $227.0K | 0.00% | +10,000 | New |
| Maven Securities LTD | 11,106 | $213.0K | 0.02% | +11,106 | New |
| Wellington Management Group LLP | 9,192 | $209.0K | 0.00% | +9,192 | New |
| Legal & General Group Plc | 3,000 | $69.0K | 0.00% | +3,000 | New |
| Tower Research Capital LLC (TRC) | 400 | $9.00K | 0.00% | +400 | New |